P27/Kip1 expression in gliomas and its clinical significance

Chinese-German Journal of Clinical Oncology

Volumn 4, Issue 6, 2005, Pages 381-383

  Shi, Wei ^a   Bai, Bin ^a   Wang, Fangru ^a   Liu, Chongxiao ^a   Song, Ying ^a  

^a THE SECOND AFFILIATED HOSPITAL OF XI AN JIAOTONG UNIVERSITY   (China)

Author keywords

Glioma; Immunohistochemistry; P27 Kip1; Prognosis

Indexed keywords

EID: 30744434382     PISSN: 16101979     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10330-004-0285-1     Document Type: Article

References (10)

1. 1/Bcl-1 and p27/Kip1 expression in gliomas, and their possible prognostic roles. Chin Med J, 2002, 115: 44-50.
2. Pietenpol JA, Bohlander SK, Sato Y, et al. Assignment of the human p27Kip1 gene to 12p13 and its analysis in leukemias. Cancer Res, 1995, 55: 1206-1210.
3. Jellinek M, Castaneda M, Garvin PJ, et al. Oxidation-reduction maintenance in organ preservation. Arch Surg, 1985, 120: 439-442.
4. Kawamata N, Morosetti R, Miller CW, et al. Molecular analysis of the cyclin-dependent kinase inhibitor gene p27Kip1 in human malignancies. Cancer Res, 1995, 55: 2266-2269.
5. Nourse J, Firpo E, Flanagan WM, et al. Interleukin-2-mediated elimination of the p27Kip1 cyclin-dependent kinase inhibitor prevented by rapamycin. Nature, 1994, 372: 570-573.
6. Peng D, Fan Z, Lu Y, et al. Anti-epidermal growth factor receptor monoclonal antibody 225 up-regulates p27Kip1 and induces G1 arrest in prostatic cancer cell line DU145. Cancer Res, 1996, 56: 3666-3669.
7. Yasui W, Kudo Y, Semba S, et al. Reduced expression of cyclin-dependent kinase inhibitor p27Kip1 is associated with advanced stage and invasiveness of gastric carcinomas. Jpn J Cancer Res, 1997, 88: 625-629.
8. Loda M, Cukor B, Tam SW, et al. Increased proteasome-dependent degradation of the cyclin-dependent kinase inhibitor p27 in aggressive colorectal carcinomas. Nat Med, 1997, 3: 231-234.
9. Esposito V, Baldi A, De Luca A, et al. Prognostic role of the cyclin-dependent kinase inhibitor p27 in non-small cell lung cancer. Cancer Res, 1997, 57: 3381-3385.
10. Tsihlias J, Kapusta LR, DeBoer G, et al. Loss of cyclindependent kinase inhibitor p27Kip1 is a novel prognostic factor in localized human prostate adenocarcinoma. Cancer Res, 1998, 58: 542-548.